IOVA Class Action Lawsuit Reminder issued by Levi & Korsinsky

Investors who have suffered losses are reminded by the law firm Levi & Korsinsky of the upcoming deadline in the class action lawsuit against Iovance Biotherapeutics, Inc. The deadline for investors to participate in the lawsuit is July 14, 2025. The lawsuit is being filed on behalf of those who purchased shares of Iovance Biotherapeutics between May 12, 2021, and March 14, 2025.

The lawsuit alleges that the defendants made false and misleading statements about the company’s business, operations, and prospects. These statements caused the company’s stock price to be artificially inflated during the class period. The lawsuit claims that the truth about Iovance Biotherapeutics’ business was revealed through a series of disclosures, causing the stock price to fall.

Investors who suffered losses as a result of these alleged false and misleading statements may be eligible to participate in the class action lawsuit. It is important for investors to act quickly, as the deadline to join the lawsuit is approaching. By participating in the lawsuit, investors may be able to recover some of their losses.

Investors who purchased shares of Iovance Biotherapeutics between May 12, 2021, and March 14, 2025, and suffered losses as a result of the alleged false and misleading statements are encouraged to contact Levi & Korsinsky. The law firm is dedicated to helping investors seek justice and recover losses incurred as a result of securities fraud.

Levi & Korsinsky is a national firm with extensive experience in securities litigation. The firm has a proven track record of success in representing investors who have been harmed by securities fraud. Levi & Korsinsky is committed to holding companies and executives accountable for their actions and helping investors recover losses incurred as a result of securities fraud.

Investors who are interested in participating in the class action lawsuit against Iovance Biotherapeutics should contact Levi & Korsinsky before the July 14, 2025 deadline. By taking action and seeking justice, investors may be able to recover some of the losses they suffered as a result of the alleged false and misleading statements made by the defendants.

For more information on how to participate in the class action lawsuit against Iovance Biotherapeutics, investors can contact Levi & Korsinsky. The law firm is dedicated to helping investors seek justice and recover losses incurred as a result of securities fraud.